ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

About ASN

Talat Alp Ikizler, MD, FASN

ASN Biography
Dr. Ikizler is currently the Director of Division of Nephrology and Hypertension, Vice-Chair for Clinical Research, Department of Medicine, Professor of Medicine, and Catherine McLaughlin Hakim Chair in Vascular Biology at the Vanderbilt University School of Medicine (VUSM) in Nashville, Tennessee. He is a member of American Society of Clinical Investigation (ASCI) and Association of American Physicians (AAP). Dr. Ikizler's clinical and research interests and expertise are focused on the care of the patients with chronic kidney disease and acute kidney injury. He also has research interest in nutritional and metabolic aspects of acute and chronic diseases.

Current Position/Titles

Catherine McLaughlin-Hakim Chair in Vascular Biology; Professor of Medicine; Director, Division of Nephrology and Hypertension, Vanderbilt University Medical Center

Degrees/Training

  • M.D.: Istanbul University School of Medicine, Istanbul, Turkey 1987
  • Internal Medicine Residency: Sisli Etfal Hospital, Istanbul, Turkey: 1988 - 1991; Vanderbilt University Medical Center: 1996 - 1998
  • Nephrology Fellowship: Vanderbilt University Medical Center: 1993 - 1996
  • Research/Post-Doc Training: Vanderbilt University Medical Center: 1992 - 1996

ASN Service

  • Program Committee Annual Meeting Member, 2009, 2013
  • ASN Dialysis Advisory Committee, 2003-2006
  • Chairman, ASN - NTDS Current and Emerging Threats Committee, 2018 - present
  • Associate Editor: Journal of the American Society of Nephrology, 2007 - 2013
  • Member, ASN COVID-19 Response Team, 2020 - present
  • Abstract Selection Committee Member, multiple years
  • ASN Board Review Course, multiple years

Leadership Positions

  • Associate Editor: Journal of the American Society of Nephrology (2007 - 2013), Kidney International (2018 - present)
  • President: National Kidney Foundation of Middle Tennessee (2002 - 2004), International Society of Nutrition and Metabolism in Kidney Disease (2008 - 2010)
  • Chair, ABIM Nephrology Subspecialty Exam Writing Committee (2014 - 2018)
  • Member, FASEB Board of Directors ASCI representative (2017 to present)
  • Director, Master of Science in Clinical Investigation Program, Vanderbilt University (2006 - 2017)
  • Chair, Kidney Disease Outcomes Quality Initiative - Academy of Nutrition and Dietetics Nutrition in Kidney Disease Clinical Practice Guideline Work Group

Honors

  • National Kidney Foundation Volunteer Service Award (2003)
  • Member, American Society of Clinical Investigation (inducted in 2005)
  • National Kidney Foundation - Joel Kopple Award (2011)
  • International Society of Renal Nutrition and Metabolism Thomas Addis Award (2012)
  • Vanderbilt University Medical Center, Excellence in Mentoring Translational Scientists Award (2016)
  • Samir and Grace Tuma Award (2018)
  • Member, Association of American Physicians (inducted in 2019)
  • Best Doctors (2009 - present)

Board Certification

  • Internal Medicine, Nephrology

Research Interests

Dr. Ikizler's research focuses on mechanisms leading to adverse outcomes in patients with kidney disease, with a specific emphasis on nutritional and metabolic effects of uremia and extracorporeal therapies. His group has delineated mechanisms by which kidney diseases lead to protein and energy wasting, metabolic abnormalities and cardiovascular disease (CVD). Their research informed clinical guidelines on nutritional and metabolic support of patients with acute and chronic kidney disease. His work has identified non-traditional risk factors for CVD in kidney disease, leading to number of randomized clinical trials examining anti-inflammatory and anti-oxidant therapies as well as healthy life style interventions.

Personal Statement

As an Executive Council member, I will be committed to enhance the mission of American Society of Nephrology: promote the highest quality care for patients with kidney disease, support cutting-edge research and engage nephrologists as leaders in medicine through education and mentoring. I am a clinician committed to improving lives of patients with kidney disease, a physician-scientist dedicated to patient-oriented research and an educator devoted to mentoring younger generations of scientists. These experiences will allow me to execute ASN's mission with the upmost level of enthusiasm and determination and with the highest degree of attention to inclusion and diversity.